NCAM1 and plasma cell neoplasm: Plasma cell dyscrasias are also not easily identified in the ClearLLab system, which lacks CD138 and other markers useful for diagnoses and follow-up of PCD.22,29,30 Although CD38, CD56, and CD45, used to identify plasma cells, are included in the ClearLLab panels, plasma cell identification is not definitive.